A Placebo-controlled Study for SPM 962 in Early Parkinson's Disease Patients Trial Phase 2 Completed March 18, 2014
A Long-Term Extension Trial From Late Phase II of SPM 962 in Advanced Parkinson's Disease Patients Trial Phase 2 Completed March 18, 2014
A Long-Term Extension Trial From Phase II/III of SPM 962 in Early Parkinson's Disease Patients Trial Phase 2 Completed March 18, 2014
A Long-Term Extension Trial From of SPM 962 in Advanced Parkinson's Disease Patients Trial Phase 3 Completed March 18, 2014
A Dose-finding Study for SPM 962 in Advanced Parkinson's Disease Patients Trial Phase 2 Completed March 18, 2014
A Dose-ranging Study for SPM 962 in Parkinson's Disease Patients Trial Phase 2 Completed March 18, 2014
Ophthalmologic Safety Study of Pramipexole Immediate Release (IR) Versus Ropinirole in Early Parkinson's Disease (PD) Patients Trial Phase 4 Completed March 13, 2014
Study in Advanced Parkinson's Disease Patients With Predictable Motor Fluctuations Trial Phase 2 Completed March 9, 2014
The Effects of the Rivastigmine Patch on Parkinson's Disease With Memory and/or Thinking Problems Trial Phase 4 Completed Feb. 25, 2014
Executive Control Analysis in Patients Suffering From Parkinson Disease and Treated by Deep Brain Stimulation Trial N/A Completed Feb. 24, 2014
A Randomised Placebo Controlled Study of OXN PR for Severe Parkinson's Disease Associated Pain Trial Phase 3 Completed Feb. 5, 2014
Pedunculopontine Nucleus Stimulation for Gait Disorders in Parkinson's Disease Trial Phase 1 Completed Feb. 4, 2014
BEWARE: Body Awareness Training in the trEatment of Wearing-off Related Anxiety in Patients With paRkinson's Disease Trial N/A Unknown Feb. 3, 2014
Investigating the Pathophysiological Roles of Cortical, Sub-thalamic Nuclear and Pedunculo-pontine Nuclear Oscillation in Movement Termination of Parkinson Disease Patients Trial N/A Completed Jan. 29, 2014
The Effects of Auditory Cueing on Rhythmic Movement and Cortical Excitability in Patients With Parkinson's Disease Trial N/A Unknown Jan. 15, 2014
Rasagiline for the Symptomatic Treatment of Fatigue in Parkinson's Disease Trial Phase 4 Completed Jan. 9, 2014